Detalhe da pesquisa
1.
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
Drug Saf
; 46(7): 689-702, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294532
2.
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.
Front Pharmacol
; 14: 1207976, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663263